2023
DOI: 10.4149/neo_2022_221118n1112
|View full text |Cite
|
Sign up to set email alerts
|

Triptonide inhibits growth and metastasis in HCC by suppressing EGFR/PI3K/AKT signaling

Abstract: Liver cancer represents one of the deadliest cancers, with rising incidence worldwide [1]. For all stages combined, 5-year patient survival in liver cancer is only 20%, i.e., the second lowest among all cancers; hepatocellular carcinomas (HCCs) comprise 75~85% of primary liver cancers [2,3].Conventional cancer therapeutic strategies, including surgery, chemotherapy and radiotherapy, exert

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 24 publications
(26 reference statements)
0
0
0
Order By: Relevance